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Abstract
Introduction: In trigeminal neuralgia, when drug treatment proves ineffective, other management options must be 
considered. In this context, conventional radiofrequency of Gasser’s ganglion is a safe and effective alternative.
Material and Methods: We describe 5 patients with long-evolving trigeminal neuralgia subjected to conventional 
radiofrequency according to the Sweet technique, with a follow-up of two years.
Results: Pain relief was complete after two months in all cases. One patient suffered an unexpected episode of 
nausea, vomiting and foul odor sensation that subsided after three days of rest and drug treatment. Three patients 
described non-painful hypoesthesia in the region of the treated nerve branch that subsided within three months. 
The patients remained free of symptoms over long-term follow-up. In one case the same radiofrequency technique 
had to be repeated after 21 months because of the reappearance of symptoms in the same zone, followed by im-
mediate pain relief.
Conclusions: In our series of patients trigeminal neuralgia was not controlled by drug treatment, and conventional 
radiofrequency targeted to Gasser’s ganglion proved very effective, with no major complications.
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Introduction
Primary trigeminal neuralgia is one of the most painful 
conditions seen in human clinical practice, and while 
many treatments have been developed to afford pain 
relief, none of them are uniformly effective (1). Radi-
ofrequency (RF) ablation is a minimally invasive tech-
nique used on an outpatient basis that has been applied 
to trigeminal neuralgia when drug treatment proves 
ineffective (2). The typical clinical characteristics of 
trigeminal neuralgia comprise fulgurant or stabbing 
pain in the form of bursts that last for seconds, with 
the existence of trigger factors or zones. However, not 
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all forms of facial pain in the territory of the V cranial 
nerve necessarily meet all these criteria. As a result, 
Bruchiel established a subclassification of trigeminal 
neuralgia (Table 1) (3). The most frequent form of pre-
Pain category Pain profile
Idiopathic (type I) trigeminal neuralgia Spontaneous onset (>50% episodic pain)
Atypical (type II) trigeminal neuralgia Spontaneous onset (> 50% constant pain)
Trigeminal neuropathy Non-intentional trigeminal damage (trauma, sinus surgery)
Deafferentiation trigeminal pain Iatrogenic trigeminal damage (following neurodestructive 
procedure)
Secondary or symptomatic trigeminal neural-
gia
Multiple sclerosis
Table 1. Subclassification of trigeminal neuralgia.
(Subtypes drawn from the classification of Bruchiel, revised in 2003)(3)
Name of procedure Surgical details Current evaluation
Microvascular decompression (Jan-
netta technique)
Retromastoid craniotomy, nerve root 
vascular decompression
Most effective treatment option
Radiofrequency gangliolysis (Sweet 
technique)
Percutaneous needle insertion: ther-
mal destruction of Gasser’s ganglion
Highly effective
Glycerol gangliolysis Percutaneous needle insertion: che-
mical destruction of the trigeminal 
fibers
Highly effective
Percutaneous balloon microcom-
pression
Percutaneous needle insertion: me-
chanical destruction of the trigemi-
nal fibers
Highly effective
Table 2. Invasive techniques for the treatment of trigeminal neuralgia.
sentation of the pain is in the territories of trigeminal 
branches V2 and V3 (32%), and in those cases where 
only one nerve branch is affected, the most common 
presentations correspond to V2 (17%) and V3 (15%)
(1). A number of studies have compared different tech-
niques for the treatment of trigeminal neuralgia (4). Ac-
cording to the most recent publications, microvascular 
surgery offers the best results in terms of improvement 
in patient quality of life and pain over the long term. 
The percutaneous techniques (radiofrequency, glycerol 
and balloon procedures) offer very good efficacy (over 
90%), but with a higher relapse rate – with no major 
differences among them (Table 2). In elderly patients, 
radiofrequency ablation is usually a better choice than 
surgical treatment, due to the morbidity-mortality as-
sociated with surgery (1).
The present study describes a series of patients with 
long-evolving trigeminal neuralgia subjected to con-
ventional radiofrequency.
Material and Methods
Between January 2006 and December 2007, we re-
viewed 13 patients with trigeminal neuralgia seen in a 
medical-surgical unit of a University clinic; of these 5, 
complied with the following criteria for treatment with 
conventional radiofrequency:
a. Typical or atypical primary trigeminal neuralgia with 
a duration of over two years.
b. Inefficacy of drug treatment.
c. A pain visual analog scale (VAS) score of over 7/10, 
with poor quality of life because of the pain.
d. Absence of concomitant disorders capable of ac-
counting for the symptoms.
e. Normal brain magnetic resonance imaging findings.
The inclusion criteria were the obtainment of informed 
consent to participation in the study and a clinical fol-
low-up of two years. The treated patients had a mean 
age of 64.8 years (range 55-76); there were three women 
and two men. The distribution according to the affected 
trigeminal nerve branch was as follows: four patients 
suffered pain in the territory of the third branch (V3)
(3 right side and 1 left side), and one patient suffered 
pain in the region of the second branch. Two subjects 
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Sex Age Diagnosis Location Antecedent Duration Medication
Female 76 Typical trigeminal n. V3 right Premolar removal 5 years Amitriptyline
Female 63 Atypical trigeminal n. V2 left No 7 years Occasional corticosteroids
Female 69 Typical trigeminal n. V3 right No 4 years Carbamazepine
Male 61 Typical trigeminal n. V3 left Premolar removal 27 years Carbamazepine
Male 55 Typical trigeminal n. V3 right No 15 years
Carbamazepine,
amitriptyline,
clonazepam
Table 3. Clinical data of the study sample.
Fig. 1. Visualization of the foramen ovale in the submental and 
oblique projections.
Fig. 2. Sweet’s technique: Needle insertion through the foramen 
ovale, targeted to the second trigeminal branch (central).
had undergone extraction of a premolar in the painful 
quadrant before the actual onset of pain. However, in 
both cases the clinical manifestations of neuralgia were 
typical (Table 3). Only one patient presented atypical 
neuralgia characterized by constant pain associated to 
paroxysmal episodes. In all cases the pain had been 
present for a long time (between 4-27 years, with a me-
dian of 11.4 years). All of the patients had received co-
adjuvant analgesia (carbamazepine, amitriptyline) until 
such treatment proved ineffective or produced side ef-
fects requiring treatment suspension (Table 3). At the 
time of radiofrequency ablation, all of the patients des-
cribed their pain as terrible, with a great impact upon 
quality of life.
All of the patients received an explanation of the dif-
ferent treatment options, and accepted radiofrequency 
treatment of Gasser’s ganglion.
Conventional radiofrequency targeted to Gasser’s gan-
glion is carried out under radioscopic control, follow-
ing the technique described by Sweet (5). The patient 
is placed in supine decubitus, with an initial submental 
radioscopic projection. From here the projection is in-
clined obliquely towards the affected side until the fo-
ramen ovale is visualized medially with respect to the 
mandibular ramus and lateral to the maxilla (Fig. 1). 
Depending on the nerve branch requiring treatment, the 
target is more medial (V1 or ophthalmic) or more lateral 
(V3 or mandibular) (Fig. 2). A needle (Sluijter-Mehta 
cannula) is inserted 2-3 cm from the lateral margin of 
the mouth, according to whether the target is more lat-
eral (2 cm) or more medial (3 cm). It is important to 
place a finger in the mouth of the patient to ensure that 
the needle does not perforate the oral mucosa. Follow-
ing insertion, the radioscopic projection is shifted to 
lateral, to assess the depth to which the needle must be 
advanced, and to avoid moving too close to the clivus 
and sella turcica (Fig. 3). Sensory testing is performed 
to better locate the branch to be treated, with a motor 
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Fig. 3. Lateral projection: confirm needle insertion depth. Ob-
serve the clivus and sella turcica.
Patient 1 week 1 month 3 months 1 year 2 years
Female 76 yrs. Hypoesthesia
VAS 2/10
Hypoesthesia
No pain
No pain No pain No pain
Female 63 yrs. VAS 3/10 VAS 2/10 VAS 2/10 VAS 2/10 VAS 2/10
Female 69 yrs. Hypoesthesia
VAS 3/10
Hypoesthesia
VAS 1/10
No pain No pain No pain
Male 61 yrs. Hypoesthesia
VAS 1/10
Hypoesthesia
No pain
No pain No pain Repeat RF
Male 55 yrs. Cacosmia
VAS 5/10
VAS 4/10 No pain Carba-
mazepine
No pain No pain
Table 4. Post-treatment course.
test that only proves positive with the third trigeminal 
branch. The procedure requires deep patient sedation, 
and three lesions are usually made (60 seconds at 60º-
70ºC), with periods of awakening and re-evaluation af-
ter each of them. In the case of relapse, the procedure is 
repeated with the same characteristics.
Results
The technique was carried out without problems in all 
patients, with positive sensitivity tests (at < 0.3 volts) 
and a positive motor test in the case of the third branch. 
Three lesions were made in the described temperature 
interval (60-65-75ºC). Following each lesion we checked 
the corneal reflex and the existence of hypoesthesia of 
the second and third trigeminal branches (consistent 
with the lesions made). The immediate postoperative 
course proved excellent in all cases.
Thirty hours after RF treatment, one patient suffered an 
unexpected episode of nausea, vomiting and foul odor 
sensation that subsided after three days of rest and drug 
treatment with ondansetron (4 mg via the oral route 
every 8 hours) and corticosteroids (dexamethasone 4 
mg via the oral route per day). The olfactory symptoms 
slowly subsided, leaving persistent dull pain that disap-
peared after two months. In the rest of the patients pain 
relief was immediate and lasting.
Three patients described non-painful hypoesthesia in the 
region of the treated nerve branch that subsided within 
three months (Table 4). As regards the long-term out-
come, all the patients were found to be free of symptoms 
and without medication after 6 months. In one case the 
same radiofrequency technique had to be repeated after 
21 months because of the reappearance of symptoms in 
the same zone, followed by immediate pain relief.
Discussion
Primary trigeminal neuralgia most often manifests be-
tween 50 and 70 years of age. In 90% of the cases, the 
symptoms first appear after age 40. The prevalence is 
higher in women than in men (1.5:1 proportion). In our 
series the women were within the established age range 
(4), though the males were under age 40 at the time of 
symptoms onset. The gender distribution was consistent 
with the proportion described in the literature. Typical 
trigeminal neuralgia must meet a series of clinical di-
agnostic criteria (6). In our series, four of the patients 
presented typical (or type I) neuralgia, while one subject 
suffered constant pain with associated paroxysmal epi-
sodes. When dealing with trigeminal neuralgia, we must 
discard other underlying disorders such as traumatisms, 
tumors, connective tissue diseases, infections or demy-
elinating disorders (7). In our patients the existence of 
concomitant pathology was ruled out by brain magnetic 
resonance imaging. Regarding distribution according to 
the different nerve branches, the association of V2 and 
V3 involvement is known to be the most common presen-
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tation, though in our series most of the subjects presented 
pain of the third trigeminal branch, and only one patient 
suffered pain corresponding to the second branch.
Regarding treatment, the initial approach always con-
sists of drug therapy. Carbamazepine is usually able to 
reduce the pain by 70% (1). Other drug substances have 
also been used, with more irregular results, including 
oxcarbazepine, amitriptyline (8), gabapentin, pregaba-
lin and baclofen. Although microvascular decompres-
sion surgery affords the best results (Table 4), conven-
tional radiofrequency could be an effective technique 
(scientific level of evidence 2B+), and would avoid the 
morbidity-mortality associated to surgery – particularly 
in elderly patients, where RF ablation therefore could 
be regarded as the first treatment choice (1). However, 
radiofrequency ablation is not without complications in 
the form of a diminished corneal reflex (5.7%), masseter 
muscle weakness or paralysis (4.1%), dysesthesia (1%), 
painful anesthesia (0.8%), keratitis (0,6%) or temporal 
paralysis of cranial nerves III and IV (0.8%).
The development of foul odor sensation following radio-
frequency has not been described in the literature. We are 
unable to find a physiopathological explanation for this 
condition, recorded in one of our patients, not even when 
treatment is targeted to the second trigeminal branch, 
which conducts sensitivity from the nasal portion. 
Despite the few complications of conventional radiofre-
quency, pulsed radiofrequency appears to be a reason-
able alternative in the treatment of trigeminal neuralgia, 
given its non-ablative nature. However, the results ob-
tained in the only randomized study published to date 
have been disappointing (9).
Conclusion
In our series of patients trigeminal neuralgia was not 
controlled by drug treatment, and conventional radio-
frequency targeted to Gasser’s ganglion proved very ef-
fective, with no major complications.
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